
@Article{,
AUTHOR = {Silvia Stojanov, Florian Hoffmann, Anja Kéry, Ellen D. Renner, Dominik Hartl, Peter Lohse, Kristina Huss, Peter Fraunberger, James D. Malley, Stephanie Zellerer, Michael H. Albert, Bernd H. Belohradsky},
TITLE = {Cytokine proﬁle in PFAPA syndrome suggests continuous inﬂammation and reduced anti-inﬂammatory response},
JOURNAL = {European Cytokine Network},
VOLUME = {17},
YEAR = {2006},
NUMBER = {2},
PAGES = {90--97},
URL = {http://www.techscience.com/ECN/v17n2/66154},
ISSN = {1952-4005},
ABSTRACT = {PFAPA syndrome is characterized by periodic episodes of high fever, aphthous stomatitis,
pharyngitis, and/or cervical adenitis. It is of unknown etiology and manifests usually before 5 years of age. We
determined serum and intracellular cytokine levels in six PFAPA patients (4 males, 2 females, mean age 8 years
(± 1.2 SEM), range 4-13) during the symptom-free period as well as 6-12 hours and 18-24 hours after fever onset.
Values were compared to age-matched, healthy controls. Febrile PFAPA attacks led to a signiﬁcant increase in
IL-6 and IFN-γ serum concentrations compared to symptom-free periods and to controls, with IL-1β, TNF-α and
IL-12p70 levels being signiﬁcantly higher than in controls. Lymphocytic IFN-γ and CD8+ IL-2 production was
consistently signiﬁcantly elevated compared to healthy children. During the asymptomatic period, serum
concentrations of IL-1β, IL-6, TNF-α and IL-12p70 were signiﬁcantly increased compared to controls.
Intracellular TNF-a synthesis was not elevated at any time point. Soluble TNFRp55 levels were even lower in
between febrile episodes, reaching values comparable to controls during attacks, whereas soluble TNFRp75 levels
increased during attacks compared to healthy children. Anti-inﬂammatory IL-4 in serum was at all times lower
in PFAPA patients compared to controls with no difference in levels of intracellular IL-4 and IL-10 or serum
IL-10. The observed increase of pro-inﬂammatory mediators, even between febrile attacks, suggests a dysregu-lation
of the immune response in PFAPA syndrome, with continuous pro-inﬂammatory cytokine activation and a
reduced anti-inﬂammatory response.},
DOI = {}
}



